Gossamer Bio shareholders approved convertible note exchange proposals at special meeting
GOSS•Special meeting approved note exchange proposals and reverse split authority
Gossamer Bio held a special stockholder meeting on July 14, 2026.
Stockholders adopted proposals tied to the previously completed exchange of the 5.00% Convertible Senior Notes due 2027.
They also authorized the board to execute a reverse stock split; the split had not been carried out as of July 27, 2026.
The company expects to implement the reverse stock split in or shortly following Q3 2026, subject to final board action.
